William Blair analyst Sami Corwin reiterated an Outperform rating on Beam Therapeutics Inc (NASDAQ: BEAM)The analyst commented, "We view today’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE